SCHEMBL24303333

SCHEMBL24303333

CC1CCC2C(=O)N(C(C)C)C(=O)C2C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.42
LMNA P02545 2/20 0.41
RAB9A P51151 1/20 0.41
STAT3 P40763 1/20 0.38
ALDH1A1 P00352 6/20 0.36
GAA P10253 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PKM P14618 1/20 0.36
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
L3MBTL1 Q9Y468 3/20 0.34
MAPT P10636 2/20 0.34
MAPK1 P28482 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
ABCB1 P08183 1/20 0.33
HTT P42858 1/20 0.32
MT-CO2 P00403 1/20 0.31
ALOX5 P09917 1/20 0.31
PIK3CD O00329 1/20 0.31
TRPA1 O75762 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17736731 0.81 CYP19A1 (0.33) RAB9AALDH1A1GAASMN1; SMN2KMT2A
SCHEMBL13684329 0.81 CYP19A1 (0.33) RAB9AALDH1A1GAASMN1; SMN2KMT2A
SCHEMBL17532414 0.80 LMNA (0.39) POLBLMNARAB9ASTAT3ALDH1A1
SCHEMBL27372219 0.78
SCHEMBL9906961 0.78 POLB (0.45) POLBLMNARAB9ASTAT3ALDH1A1
SCHEMBL13532554 0.77 SMN1; SMN2 (0.39) POLBLMNARAB9AALDH1A1SMN1; SMN2
SCHEMBL12308315 0.77 SMN1; SMN2 (0.39) POLBLMNARAB9AALDH1A1SMN1; SMN2
SCHEMBL13684308 0.77 MAPK1 (0.37) POLBLMNARAB9AALDH1A1GAA
SCHEMBL17736732 0.77 CYP2D6 (0.34) ALDH1A1GAAKMT2AMEN1MAPT
SCHEMBL3199393 0.76 POLB (0.44) POLBLMNARAB9ASTAT3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303578-A1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND PRIMEGENE (BEIJING) CO., LTD. (CN) 2023-09-28 US disclosed
EP-4206205-A1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND Primegene (Beijing) Co., Ltd. (CN) 2023-07-05 EP disclosed
WO-2022042577-A1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND 北京普祺医药科技有限公司 2022-03-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303578-A1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND DPYD, RPLP2, DHPS POLB 348/4885LMNA 4225/4885RAB9A 2174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.